Cat Pancreatitis and Triaditis Management

Triaditis involves concurrent pancreatitis, IBD and cholangitis in cats. Recognising and managing all three conditions simultaneously is essential for welfare recovery.

Key Facts

Triaditis occurs in up to 50% of cats with inflammatory liver, bowel or pancreatic disease
The three conditions share a common inflammatory pathway and frequently co-occur
Histopathological diagnosis from multiple tissue biopsies is required for definitive diagnosis
Treatment requires simultaneous management of all three conditions for optimal response
Ursodeoxycholic acid supports biliary function while prednisolone manages the inflammatory component

Welfare Considerations

Cats with triaditis experience multi-organ inflammatory disease causing nausea, anorexia, weight loss and abdominal pain from multiple simultaneous sources. Managing only one component while missing concurrent disease results in treatment failure and prolonged suffering. Tissue biopsy allows definitive diagnosis of each component and guides specific treatment selection. Nutritional support through enteral feeding prevents hepatic lipidosis during the anorexic period. Combination treatment addressing all three inflammatory conditions simultaneously provides the fastest welfare recovery.

What You Can Do

Request full-thickness multiple organ biopsies if triaditis is suspected
Ensure treatment addresses hepatic, intestinal and pancreatic inflammation together
Place a feeding tube early to prevent hepatic lipidosis from prolonged anorexia
Give ursodeoxycholic acid for cholangitis and prednisolone for the inflammatory components
Monitor liver enzymes, pancreatic markers and clinical signs monthly during treatment